Newsletter I&I nieuws
9 aug: Reactie op het bericht over het transparantieregister
Hieronder mijn reactie op het recente artikel op www.indepen.eu en de daarop volgende Twitter- en LinkedIn berichten over de transparantie ten aanzien van samenwerkingen tussen academische ziekenhuizen en de (farmaceutische) industrie.
Lees meerSep 25: New insights in noncytotoxic functions of granzymes
PhD research by Liling Shan (UMC Utrecht) has generated new insights into the noncytotoxic functions of granzymes in inflammation and antiviral immunity.
Lees meerJun 25: UMC Utrecht participates in nasal airway cell model development project for COVID-19 drugs
There is a high demand for SARS-CoV-2 antiviral therapies that may limit COVID-19 severity in susceptible individuals. At the end of March, Health~Holland set up a call for COVID-19 related research proposals. Recently, it was announced that that so far 17 projects have been granted a Public Private Partnership (PPP) Allowance to start their research. CLEAR COVID-19 is one of the projects coordinated by UMC Utrecht that focuses on development of nasal airway epithelial cell models for COVID-19 drug development.
Lees meer